Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

89bio Inc

ETNB
Current price
9.15 USD +0.63 USD (+7.39%)
Last closed 8.52 USD
ISIN US2825591033
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 928 897 792 USD
Yield for 12 month -19.31 %
1Y
3Y
5Y
10Y
15Y
ETNB
21.11.2021 - 28.11.2021

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California. Address: 142 Sansome Street, San Francisco, CA, United States, 94104

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30.13 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-273 000 USD

Last Year

-240 000 USD

Current Quarter

Last Quarter

-12 000 USD

Key Figures ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -303 812 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -41.36 %
PEG Ratio
Return On Equity TTM -73.31 %
Wall Street Target Price 30.13 USD
Revenue TTM
Book Value 3.56 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.96 USD
Diluted Eps TTM -2.96 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ETNB

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation ETNB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.75
Price Book MRQ 2.46

Financials ETNB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ETNB

For 52 weeks

7.00 USD 16.63 USD
50 Day MA 8.39 USD
Shares Short Prior Month 5 517 407
200 Day MA 8.94 USD
Short Ratio 6.09
Shares Short 5 877 277
Short Percent 6.25 %
Dividend information is being updated